middle.news
Algorae Secures Exclusive Deal with Zydus for 10 Medicines in ANZ Markets
9:08am on Tuesday 28th of April, 2026 AEST
•
Pharmaceuticals
Read Story
Algorae Secures Exclusive Deal with Zydus for 10 Medicines in ANZ Markets
9:08am on Tuesday 28th of April, 2026 AEST
Key Points
Exclusive licensing agreement for 10 products with Zydus Lifesciences
Focus on injectable, oral, and specialty medicines for ANZ
Commercialisation contingent on TGA and regulatory approvals
Partnership strengthens Algorae’s ANZ commercial platform
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE